Evidence map›Paper›PMID 34638253›Full record

ArticleCancers2021

Automated Raman Micro-Spectroscopy of Epithelial Cell Nuclei for High-Throughput Classification.

Kevin O'Dwyer, Katarina Domijan, Adam Dignam, Marion Butler, Bryan M Hennelly

Abstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Testing Raman spectroscopy as a diagnostic approach for Lyme disease patients.Frontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kevin O'DwyerDepartment of Electronic Engineering, Maynooth University, Maynooth, Ireland.ORCID 0000-0001-7405-9679
Katarina DomijanDepartment of Mathematics and Statistics, Maynooth University, Maynooth, Ireland.ORCID 0000-0002-4268-2236
Adam DignamDepartment of Biology, Maynooth University, Maynooth, Ireland.ORCID 0000-0003-4126-2819
Marion ButlerDepartment of Biology, Maynooth University, Maynooth, Ireland.
Bryan M HennellyDepartment of Electronic Engineering, Maynooth University, Maynooth, Ireland.ORCID 0000-0003-1326-9642

Funding

Science Foundation Ireland 15/CDA/3667
6 · The paper itself

Abstract

Raman micro-spectroscopy is a powerful technique for the identification and classification of cancer cells and tissues. In recent years, the application of Raman spectroscopy to detect bladder, cervical, and oral cytological samples has been reported to have an accuracy greater than that of standard pathology. However, despite being entirely non-invasive and relatively inexpensive, the slow recording time, and lack of reproducibility have prevented the clinical adoption of the technology. Here, we present an automated Raman cytology system that can facilitate high-throughput screening and improve reproducibility. The proposed system is designed to be integrated directly into the standard pathology clinic, taking into account their methodologies and consumables. The system employs image processing algorithms and integrated hardware/software architectures in order to achieve automation and is tested using the ThinPrep standard, including the use of glass slides, and a number of bladder cancer cell lines. The entire automation process is implemented, using the open source Micro-Manager platform and is made freely available. We believe that this code can be readily integrated into existing commercial Raman micro-spectrometers.

Indexed as

automated cytologycellular classificationhigh-throughput classificationRaman spectroscopyscreeningThinPrep

Identifiers

PMID34638253
PMCPMC8507544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.